Molecular mechanisms targeting drug-resistance and metastasis in colorectal cancer: Updates and beyond

S Al Bitar, M El-Sabban, S Doughan… - World Journal of …, 2023 - pmc.ncbi.nlm.nih.gov
Colorectal cancer (CRC) is the third most diagnosed malignancy and a major leading cause
of cancer-related deaths worldwide. Despite advances in therapeutic regimens, the number …

In silico Methods for Design of Kinase Inhibitors as Anticancer Drugs

Z Gagic, D Ruzic, N Djokovic, T Djikic… - Frontiers in …, 2020 - frontiersin.org
Rational drug design implies usage of molecular modeling techniques such as
pharmacophore modeling, molecular dynamics, virtual screening, and molecular docking to …

[HTML][HTML] p63 at the Crossroads between Stemness and Metastasis in Breast Cancer

V Gatti, L Bongiorno-Borbone, C Fierro… - International journal of …, 2019 - mdpi.com
After lung cancer, breast cancer (BC) is the most frequent cause of cancer death among
women, worldwide. Although advances in screening approaches and targeted therapeutic …

Evaluating Deep Learning models for predicting ALK-5 inhibition

GZ Espinoza, RM Angelo, PR Oliveira, KM Honorio - Plos one, 2021 - journals.plos.org
Computational methods have been widely used in drug design. The recent developments in
machine learning techniques and the ever-growing chemical and biological databases are …

2-substituted 4-aminoquinazoline derivatives as potential dual inhibitors of EGFR and HER2: an in silico and in vitro study

F Sangande, E Julianti, DH Tjahjono - Medicinal Chemistry Research, 2022 - Springer
Abstract Epidermal Growth Factor Receptor (EGFR), and Human EGFR-related Receptor 2
(HER2) are validated targets for anticancer drugs which provide synergistic effects when …

Topomer-CoMFA proposed as a tool to construct dual EGFR/HER-2 models

H de Paula, RM Angelo, KM Honorio - Journal of Molecular Modeling, 2021 - Springer
Protein kinases (in this case, HER-2 and EGFR) are involved in cancer-related diseases.
Some reports have shown unique CoMFA models using the sum of activities expressed as …

Short communication for targeting natural compounds against HER2 kinase domain as potential anticancer drugs applying pharmacophore based molecular …

S Rampogu, G Lee, R Doneti, KW Lee - Computational Biology and …, 2020 - Elsevier
Breast cancer is one of the common causes of death noticed in women globally. In order to
find effective therapeutics, the current investigation has focussed on identifying candidate …

Next generation FKBP52 targeting drugs for the treatment of prostate and breast cancer

M Cox, A Cherkasov, F Ban - US Patent 11,878,961, 2024 - Google Patents
Procedures for inhibiting hormone receptor activation include administering to a subject in
need of hormone receptor inhibition a compound having a chemical structure of a molecule …